Amdocs Statistics
Total Valuation
Amdocs has a market cap or net worth of $9.73 billion. The enterprise value is $9.88 billion.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | Sep 30, 2024 |
Share Statistics
Amdocs has 114.19 million shares outstanding. The number of shares has decreased by -3.63% in one year.
| Current Share Class | 114.19M |
| Shares Outstanding | 114.19M |
| Shares Change (YoY) | -3.63% |
| Shares Change (QoQ) | -1.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 98.09% |
| Float | 114.00M |
Valuation Ratios
The trailing PE ratio is 19.70 and the forward PE ratio is 12.01. Amdocs's PEG ratio is 1.40.
| PE Ratio | 19.70 |
| Forward PE | 12.01 |
| PS Ratio | 1.93 |
| Forward PS | n/a |
| PB Ratio | 2.75 |
| P/TBV Ratio | 21.42 |
| P/FCF Ratio | 15.62 |
| P/OCF Ratio | 13.35 |
| PEG Ratio | 1.40 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.40, with an EV/FCF ratio of 15.96.
| EV / Earnings | 20.03 |
| EV / Sales | 1.97 |
| EV / EBITDA | 10.40 |
| EV / EBIT | 13.06 |
| EV / FCF | 15.96 |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.20 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | 1.28 |
| Interest Coverage | 25.69 |
Financial Efficiency
Return on equity (ROE) is 14.05% and return on invested capital (ROIC) is 10.92%.
| Return on Equity (ROE) | 14.05% |
| Return on Assets (ROA) | 7.38% |
| Return on Capital (ROIC) | 10.92% |
| Revenue Per Employee | $163,056 |
| Profits Per Employee | $16,068 |
| Employee Count | 30,695 |
| Asset Turnover | 0.78 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Amdocs has paid $94.75 million in taxes.
| Income Tax | 94.75M |
| Effective Tax Rate | 16.03% |
Stock Price Statistics
The stock price has increased by +1.80% in the last 52 weeks. The beta is 0.75, so Amdocs's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +1.80% |
| 50-Day Moving Average | 88.04 |
| 200-Day Moving Average | 85.59 |
| Relative Strength Index (RSI) | 38.32 |
| Average Volume (20 Days) | 715,792 |
Short Selling Information
| Short Interest | 2.86M |
| Short Previous Month | 2.85M |
| Short % of Shares Out | 2.87% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.06 |
Income Statement
In the last 12 months, Amdocs had revenue of $5.00 billion and earned $493.20 million in profits. Earnings per share was $4.25.
| Revenue | 5.00B |
| Gross Profit | 1.75B |
| Operating Income | 756.70M |
| Pretax Income | 618.21M |
| Net Income | 493.20M |
| EBITDA | 949.76M |
| EBIT | 756.70M |
| Earnings Per Share (EPS) | $4.25 |
Full Income StatementBalance Sheet
The company has $514.33 million in cash and $789.74 million in debt, giving a net cash position of -$275.41 million or -$2.41 per share.
| Cash & Cash Equivalents | 514.33M |
| Total Debt | 789.74M |
| Net Cash | -275.41M |
| Net Cash Per Share | -$2.41 |
| Equity (Book Value) | 3.50B |
| Book Value Per Share | 30.39 |
| Working Capital | 300.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $724.43 million and capital expenditures -$105.50 million, giving a free cash flow of $618.93 million.
| Operating Cash Flow | 724.43M |
| Capital Expenditures | -105.50M |
| Free Cash Flow | 618.93M |
| FCF Per Share | $5.42 |
Full Cash Flow StatementMargins
Gross margin is 35.01%, with operating and profit margins of 15.12% and 9.85%.
| Gross Margin | 35.01% |
| Operating Margin | 15.12% |
| Pretax Margin | 11.81% |
| Profit Margin | 9.85% |
| EBITDA Margin | 18.98% |
| EBIT Margin | 15.12% |
| FCF Margin | 13.50% |